高通气肺区剂量指标可预测肺癌患者放射性肺炎
研究纳入90例接受标准分割放疗(60-66 Gy/30-33次)的局部晚期非小细胞肺癌患者,基于放疗前4DCT用B样条形变配准的Jacobian行列式评估区域肺通气。高通气肺定义为体素水平扩张超过群体中位数18%的区域,功能性肺剂量指标可预测症状性2级及以上放射性肺炎,fMLD≤12.3 Gy者风险为14%,fMLD>12.3 Gy者风险显著升至35%(P=0.035)。
要点
- 高通气肺定义为体素水平扩张超过群体中位数18%的区域。
- 功能性肺剂量预测肺炎的ROC最佳点为fMLD≤12.3 Gy、fV5≤54%、fV20≤19%。
- fMLD≤12.3 Gy者2级及以上肺炎风险14%,fMLD>12.3 Gy者显著升至35%(P=0.035)。
核心结论
- 高通气肺区剂量与症状性放射性肺炎相关,治疗计划策略应侧重限制功能区域剂量。
- 这些发现为功能性肺回避放疗计划设计和临床试验设计提供了重要指标。
研究设计与样本
- 队列研究纳入90例接受标准分割放疗(60-66 Gy/30-33次)的局部晚期非小细胞肺癌患者。
- 放疗前4DCT采用B样条形变配准的Jacobian行列式估算呼吸时肺组织扩张以确定区域肺通气。
- 考虑多种基于体素的人群水平和个体水平阈值来定义高功能肺。
- 分析全肺-ITV的平均剂量和接受≥5-60 Gy的体积(MLD、V5-V60)以及高通气功能肺-ITV的对应指标(fMLD、fV5-fV60)。
- 主要终点为症状性2级及以上(G2+)放射性肺炎,采用受试者工作特征曲线(ROC)分析识别预测因素。
主要发现
- 22.2%的患者发生G2+放射性肺炎。
- G<2与G2+患者在分期、吸烟状态、COPD或化疗/免疫治疗使用方面无差异(P≥0.18)。
- 高通气肺定义为体素水平扩张超过群体中位数18%的区域。
- 所有全肺和功能性指标在有无肺炎患者间均显著不同(P≤0.039)。
- 功能性肺剂量预测肺炎的ROC最佳点为fMLD≤12.3 Gy、fV5≤54%、fV20≤19%。
关键数值与推荐
- 高通气肺定义为体素水平扩张超过群体中位数18%的区域。
- 功能性肺剂量预测肺炎的ROC最佳点:fMLD≤12.3 Gy、fV5≤54%、fV20≤19%。
- fMLD≤12.3 Gy者G2+肺炎风险14%,fMLD>12.3 Gy者35%(P=0.035)。
临床怎么用
- 原文结论指出治疗计划策略应侧重限制高通气功能区域剂量。
- 原文指出这些发现为功能性肺回避放疗计划设计和临床试验设计提供了重要指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify metrics of radiation dose delivered to highly ventilated lung that are predictive of radiation-induced pneumonitis. METHODS AND MATERIALS: A cohort of 90 patients with locally advanced non-small cell lung cancer treated with standard fractionated radiation therapy (RT) (60-66 Gy in 30-33 fractions) were evaluated. Regional lung ventilation was determined from pre-RT 4-dimensional computed tomography (4DCT) using the Jacobian determinant of a B-spline deformable image registration to estimate lung tissue expansion during respiration. Multiple voxel-wise population- and individual-based thresholds for defining high functioning lung were considered. Mean dose and volumes receiving dose ≥ 5-60 Gy were analyzed for both total lung-ITV (MLD,V5-V60) and highly ventilated functional lung-ITV (fMLD,fV5-fV60). The primary endpoint was symptomatic grade 2+ (G2+) pneumonitis. Receiver operator curve (ROC) analyses were used to identify predictors of pneumonitis. RESULTS: G2+ pneumonitis occurred in 22.2% of patients, with no differences between stage, smoking status, COPD, or chemo/immunotherapy use between G<2 and G2+ patients (P≥ 0.18). Highly ventilated lung was defined as voxels exceeding the population-wide median of 18% voxel-level expansion. All total and functional metrics were significantly different between patients with and without pneumonitis (P≤ 0.039). Optimal ROC points predicting pneumonitis from functional lung dose were fMLD ≤ 12.3 Gy, fV5 ≤ 54% and fV20 ≤ 19 %. Patients with fMLD ≤ 12.3 Gy had a 14% risk of developing G2+ pneumonitis whereas risk significantly increased to 35% for those with fMLD > 12.3 Gy (P = 0.035). CONCLUSIONS: Dose to highly ventilated lung is associated with symptomatic pneumonitis and treatment planning strategies should focus on limiting dose to functional regions. These findings provide important metrics to be used in functional lung avoidance RT planning and designing clinical trials.
引用
- Flakus MJ, Kent SP, Wallat EM, et al. Metrics of dose to highly ventilated lung are predictive of radiation-induced pneumonitis in lung cancer patients. Radiother Oncol. 2023. PMID: 36813178. doi:10.1016/j.radonc.2023.109553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。